Erythropoietic Protoporphyria — Multicentre Phase III Erythropoietic Protoporphyria Study
Citation(s)
A Phase III, Multicentre, Randomised, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Subcutanenous Bioresorbable CUV1647 Implants in Patients With Erythropoietic Protoporphyria (EPP)